and one 1-year, open-label trial that included 12 pediatric patients with POMC or LEPR deficiency or BBS aged 2 to less than 6 years (Trial 5) [see Clinical Studies (14.2, 14.3, 14.4)]
These drugs mimic natural gut hormones to slow digestion, reduce appetite, and improve blood sugar control
The FDA has been made aware of IV vitamin infusions being compounded in areas with peeling paint, stained work surfaces, dirty equipment, and unclean air vents (FDA, 10-25-21)
One consideration that partially offsets the bioavailability difference involves absorption kinetics
Neither medication is universally safer for every patient
5 Chitosan (CH) as a potential drug carrier Researchers in medical engineering are drawn to chitosan-based bio-materials as prospective carriers owing to their superior chemical, cellular, and mechanical properties that facilitate cell adhesion, growth, and division (Supernak et al., 2023)